Albert Muñoz‐Vendrell

The age at onset of relapsing-remitting multiple sclerosis has increased over the last five decades

Lucía Romero, Laura Bau, Elisabet Matas et al. · Multiple Sclerosis and Related Disorders · 2022 · 71 citations · Full text

Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients

Albert Muñoz‐Vendrell, Sergio Campoy, Edoardo Caronna et al. · The Journal of Headache and Pain · 2023 · 42 citations · Full text

Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world

Edoardo Caronna, Victor J Gallardo, Gabriella Egeo et al. · Journal of Neurology Neurosurgery & Psychiatry · 2024 · 33 citations · Full text

Baseline serum neurofilament light chain levels differentiate aggressive from benign forms of relapsing–remitting multiple sclerosis: a 20-year follow-up cohort

Pablo Arroyo Pereiro, Albert Muñoz‐Vendrell, Isabel León Moreno et al. · Journal of Neurology · 2023 · 23 citations · Full text

Oral lacosamide for the treatment of refractory trigeminal neuralgia: A retrospective analysis of 86 cases

Albert Muñoz‐Vendrell, Raquel Tena‐Cucala, Sergio Campoy et al. · Headache The Journal of Head and Face Pain · 2023 · 13 citations · Full text